Morocco – Biocodex inaugurated a new Plant in Nouaceur

January 22, 2013 1:33 pm0 commentsViews: 138

220120131409

French pharmaceutical group Biocodex inaugurated in October 2012 in the industrial zone Nouaceur its new production unit with an investment of more than 50 million DH (excluding land).

French pharmaceutical group Biocodex inaugurated in October 2012 in the industrial zone Nouaceur its new production unit with an investment of more than 50 million DH (excluding land).

This new unit, built on an area of ​​8000 m², with 4400 m² of built area will be exclusively dedicated initially to the manufacture of pharmaceutical products in the form of liquid (drinkable ampoules), with an annual manufacturing capacity of 4 million boxes.

This production platform, export-oriented, is the first born outside of French territory, the Group holding 5 Biocodex subsidiaries around the world (Belgium, Turkey, Russia, the United States and Morocco).

According to the leaders of Biocodex, Nouaceur plant, which will export its products to several countries around the world, has been designed in accordance with European standards that govern the industry of medicine. Certification by the French Agency for Safety of Medicines is expected in 2013.

Speaking on the occasion, the CEO of Biocodex, Jean-Marie Lefèvre said that the launch of this new industrial unit reflects the confidence placed in the future of the Moroccan pharmaceutical industry. He also welcomed the support provided by the Moroccan authorities of health, emphasizing the commitment of its pharmaceutical group to create opportunities for starch and contribute to the economic development of the Kingdom.

The inauguration ceremony of the plant took place in the presence of the Secretary General of the Ministry of Industry, Trade and New Technologies, the DG Biocodex Morocco, representatives of the Ministry of Health, local authorities and several other personalities from the political, economic and industrial development.

Biocodex is an independent French pharmaceutical company, created in the ’50s to develop and distribute large-scale drug promising probiotic. Biocodex is present in more than 100 countries worldwide. The Group achieved in 2011 a turnover of around 170 million euros.

[by Abdelhakim Hamdane - http://www.lematin.ma]

Comment this Post

You must be logged in to post a comment.

Recent Comments

    Tags